Ionis Pharmaceuticals, Inc.
IONS
$34.30
$1.344.07%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -1,026.51% | 4.70% | 22.31% | -14.86% | 82.33% |
| Total Depreciation and Amortization | -6.15% | -1.75% | -1.93% | 0.80% | -20.16% |
| Total Amortization of Deferred Charges | 0.60% | -1.29% | 12.91% | 12.18% | 24.36% |
| Total Other Non-Cash Items | 95.07% | -23.00% | 169.14% | -18.76% | 117.46% |
| Change in Net Operating Assets | -572.70% | -129.99% | -197.89% | 17.24% | 142.06% |
| Cash from Operations | -453.38% | -5.47% | -23.13% | -11.90% | 116.42% |
| Capital Expenditure | -3,213.19% | -322.98% | 48.10% | 57.10% | 119.79% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 440.37% | -568.21% | -15.75% | 125.57% | -112.73% |
| Cash from Investing | 355.36% | -595.98% | -10.16% | 123.37% | -112.59% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -117,123.68% | 99.93% | 99.99% | 0.00% | 99.92% |
| Issuance of Common Stock | -98.95% | 13,200.13% | 8.62% | 822.23% | 11,783.97% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | 100.00% |
| Cash from Financing | -208.33% | 1,637.32% | -98.22% | -95.21% | 179.82% |
| Foreign Exchange rate Adjustments | -247.27% | 330.26% | -132.86% | -209.62% | -39.56% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -296.01% | 155.84% | -147.42% | -254.73% | 222.55% |
